Advertisement

Author: Janine Anthes

September 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level […]

Read More

September 2019 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Infectious Disease Consultation May Lower Candida Mortality FRIDAY, […]

Read More

September 2019 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Sports Specialization Ups Injury Risk, Especially in Girls […]

Read More

September 2019 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Washington State Bans Sale of Flavored Electronic Cigarettes […]

Read More

September 2019 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Washington State Bans Sale of Flavored Electronic Cigarettes […]

Read More

September 2019 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Heart Disease May Up Risk for Allopurinol-Linked Cutaneous […]

Read More

September 2019 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Adverse Outcomes Up for Vaginal Birth After Previous […]

Read More

September 2019 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. SBRT Shortens Tx for Prostate Cancer Without Greater […]

Read More

September 2019 Briefing – Internal Medicine

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of […]

Read More

September 2019 Briefing – Critical Care

Here are what the editors at HealthDay consider to be the most important developments in Critical Care for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Crude Incidence of Candidemia 8.7 Per 100,000 […]

Read More

September 2019 Briefing – Emergency Medicine

Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC Says People Can Contract Tuberculosis From […]

Read More

September 2019 Briefing – Nephrology

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Heart Disease May Up Risk for Allopurinol-Linked Cutaneous […]

Read More

September 2019 Briefing – Pathology

Here are what the editors at HealthDay consider to be the most important developments in Pathology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC Says People Can Contract Tuberculosis From Deer […]

Read More

September 2019 Briefing – Cosmetic Surgery

Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Average Annual Premium for Workers Increased in […]

Read More

September 2019 Briefing – Pharmacy

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CVS Halts Sales of OTC Zantac MONDAY, Sept. […]

Read More

For latest news and updates
Email-id is invalid